Search Results
10
Everything
Search Filters
Tag
Biopharmaceuticals
Microbiome Disease Pipeline Insight 2025: Over 180 Drugs in Development Across 140+ Companies
March 21, 2025 12:58 ET
|
Research and Markets
Dublin, March 21, 2025 (GLOBE NEWSWIRE) -- The "Microbiome Disease - Pipeline Insight, 2025" drug pipeline report has been added to ResearchAndMarkets.com's offering.The report provides...
Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
March 20, 2025 10:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Peptide Therapeutics Market Outlook 2025-2030 - North America Maintained a Leading Position in 2024 with Share of 60.21%, Driven by the Rising Prevalence of Cancer, Metabolic Disorders and Rare Diseases
March 18, 2025 06:04 ET
|
Research and Markets
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market Size, Share & Trends Analysis Report by Application, Type (Innovative, Generic), Type of Manufacturer (Inhouse,...
Microbiome Collaboration and Licensing Agreements Trends Report 2024 and Directory of 244 Deals Signed Since 2016 by Company, Deal Type, Upfront, Milestone, Royalties and Therapy Area
March 06, 2025 11:11 ET
|
Research and Markets
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Microbiome Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
March 06, 2025 07:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, March 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
MacroGenics to Participate in Upcoming Investor Conferences
February 27, 2025 07:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Feb. 27, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Biosimilars Market Size to Hit USD 127.92 Billion by 2032, Growing at a 17.7% CAGR - SNS Insider
February 11, 2025 08:00 ET
|
SNS Insider pvt ltd
Pune, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Global Biosimilars Market Size & Growth Analysis: According to SNS Insider, The Biosimilars Market size was valued at USD 29.51 billion in 2023 and is...
Digital Biomanufacturing Market Industry Trends and Global Forecasts to 2035: Digital Twins is the Fastest Growing Segment of the Digital Biomanufacturing Market
February 10, 2025 13:35 ET
|
Research and Markets
Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Technology, Deployment Options, Type of Biologics and Key...
Opportunities in Indonesia's $22.3M Regenerative Medicine Market, 2025-2030: Rising Investments in R&D and Shift Towards Minimally Invasive Treatments
February 07, 2025 07:10 ET
|
Research and Markets
Dublin, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The "Indonesia Regenerative Medicine Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ...
Stability Testing of Pharmaceuticals and Biopharmaceuticals (Online Training Course: July 21-22, 2025) - Increase the Likelihood of Studies Receiving Regulatory Approval and Save Resources on Stability Testing
February 06, 2025 05:05 ET
|
Research and Markets
Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Stability Testing of Pharmaceuticals and Biopharmaceuticals Training Course" has been added to ResearchAndMarkets.com's offering.By attending this...